The article is not that bad. The funny part is they had to ask a professor to read the trial papers and explain them. Most people here have already gone through those studies themselves. It will be interesting when a Chinese lab releases a slightly changed version of reta and it stops being the same molecule.
Daily Mail ran a piece on reta. I know the paper is trash so this is not actual news. They usually attack GLP-1 drugs and call peptides fat jabs. Still, if you like over-the-top drama the article is worth a look. It mostly shows how publicity tries to scare people away from resellers and grey sources.